Cambridge, MA · Founded 2020 · Privately Held (backing)
Developer of a light-activated biomaterial platform designed to bring innovation in ocular and regenerative therapies. GelMEDIX is based in Cambridge, MA and was founded in 2020. It was valued at $21 million at its seed round in Feb 2026, the last priced event on record. It has raised $30.7 million across 4 recorded rounds; the latest was a $747,000 seed round in Oct 2025.
These 6 firms already write checks for companies like GelMEDIX. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.